Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takumi Fukumoto is active.

Publication


Featured researches published by Takumi Fukumoto.


Inflammation Research | 1996

Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits

Takumi Fukumoto; Akihiro Matsukawa; Susumu Ohkawara; Katsumasa Takagi; Masaru Yoshinaga

Endogenous IL-1 receptor antagonist (IL-1ra) may down-regulate part of IL-1 actions. We examined the participation of endogenous IL-1ra in the production of IL-1β in vitro. Macrophages cultured on adherent IgG produced a 100-fold molar excess of IL-1ra, compared with IL-1β. In the presence of a neutralizing monoclonal antibody (mAb) against rabbit IL-1ra, the production of antigenic IL-1β increased by 20–60%. Since the molar ratio of IL-1ra over IL-1 was 160- to 400-fold in synovial fluid (SF) of lipopolysaccharide (LPS)-induced arthritis, we examined the functional role of endogenous IL-1ra in the regulation of inflammatory responses. When measured in the presence of anti-IL-1ra mAb, masked IL-1 activity in SF became evident, with a 3- to 4-fold increment. The administration of anti-IL-1ra mAb with LPS into rabbit knee joints increased the IL-1 activity 4-fold and the production of antigenic IL-1β by 30–50%. The treatment also enhanced by 20–40% LPS-induced leukocyte infiltration and protein leakage. Therefore, endogenous IL-1ra apparently acts as a down-regulating factor for limiting delecterious effects of IL-1 by masking the biological activity and by inhibiting the production.


Journal of Leukocyte Biology | 1998

IL-8 is an essential mediator of the increased delayed-phase vascular permeability in LPS-induced rabbit pleurisy.

Takumi Fukumoto; Akihiro Matsukawa; Teizo Yoshimura; Sunao Edamitsu; Susumu Ohkawara; Katsumasa Takagi; Masaru Yoshinaga

We investigated the involvement of IL‐8 in the delayed vascular permeability (VP) in rabbit lipopolysaccharide (LPS)‐pleurisy. Maximal level of interleukin‐8 (IL‐8) was detected in pleural fluid at 2 h after LPS injection and anti‐IL‐8 inhibited the delayed VP by 90%. Injection of homologous IL‐8 induced VP, the time‐course of which preceded that of LPS‐induced delayed VP. Production of IL‐8 in LPS‐pleurisy was inhibited with anti‐tumor necrosis factor α (TNF‐α), whereas the production of TNF‐α was not affected with anti‐IL‐8. Injection of IL‐8 did not induce TNF‐α production and anti‐TNF‐α had no effect on IL‐8‐induced VP. Injection of homologous TNF‐α induced IL‐8 production and VP, and TNF‐α‐induced delayed VP was blocked with anti‐IL‐8. These results indicate important roles of IL‐8 in LPS‐induced delayed VP and that TNF‐α causes the delayed VP through the production of IL‐8. J. Leukoc. Biol. 63: 584–590; 1998.


Orthopaedics and Traumatology | 1998

Results of Surgical Treatment for Lumbosacral Radiculopathy of Lumbar Spinal Stenosis

Takaaki Sagara; Kouji Akasaki; Makoto Kimura; Hiroshi Teramoto; Takumi Fukumoto; Yoshihiko Kohno; Yoshihisa Anraku; Haruaki Takeuchi

This study investigated the operative results of the lumbosacral radiculopathy of lumbar canal stenosis. 24 cases were treated by surgery 9 cases received fenestration, 8 cases also received wide laminectomy, and in addition 7 cases received lumbar segmental fusion by instrumentation. The mean age at the time of surgery was 69.8 years (ragne; 56 to 81 years). The mean duration of follow-up was 23 months (range; 12 to 31 months).The clinical results were evaluated by the JOA score, and the recovery rate was determined by Hirabayashis method, and by the recovery ratio of radiculopathy symptoms, pain and dysesthesia of the lower extremities. The preoperative mean JOA score was 14.5 points, which changed to 20.5 points at the final check, and the mean recovery rate was 42.7%. The recovery ratio of radiculopathy pain shows a tendency to decrease as the number of decompressed intervertebral segments increase.


Cytokine | 1997

DETECTION AND CHARACTERIZATION OF IL-1 RECEPTOR ANTAGONIST IN TISSUES FROM HEALTHY RABBITS: IL-1 RECEPTOR ANTAGONIST IS PROBABLY INVOLVED IN HEALTH

Akihiro Matsukawa; Takumi Fukumoto; Takako Maeda; Susumu Ohkawara; Masaru Yoshinaga


Orthopaedics and Traumatology | 2010

Treatment of Lumbar Intraspinal Extradural Cystic Lesions

Junnosuke Nakahara; Koji Akasaki; Takaaki Sagara; Takumi Fukumoto; Akinari Tokiyoshi; Hiroyuki Watanabe; Yusuke Uehara; Makoto Kimura


Orthopaedics and Traumatology | 2007

Aspergillus Spondylitis with Paraplegia: A Case Report

Takaaki Sagara; Koji Akasaki; Makoto Kimura; Takumi Fukumoto; Yoshihiko Kono; Hiroyuki Watanabe; Shigeta Yorimitsu; Takanao Sueyoshi


Orthopaedics and Traumatology | 2006

Diagnosis of Non-neoplastic Intramedullary Spinal Cord Lesion Using MRI

Takaaki Sagara; Koji Akasaki; Makoto Kimura; Takumi Fukumoto; Yoshihiko Kono; Kiyoshi Oka; Kenichi Takemura; Haruaki Takeuchi


Orthopaedics and Traumatology | 2003

Results of Laminoplasty for Cervical Spondylotic Myelopathy in Elderly Patients

Takaaki Sagara; Koji Akasaki; Makoto Kimura; Takumi Fukumoto; Yoshihiko Kono; Korin Kuwahara; Nobuhiko Matsushita; Haruaki Takeuchi


Orthopaedics and Traumatology | 2003

Results of Ratational Acetabular Osteotomy for Advanced Osteoarthritis of the Hip

Takumi Fukumoto; Koji Akasaki; Takaaki Sagara; Makoto Kimura; Toshihiko Kouno; Korin Kuwahara; Hidehiko Matsushita; Haruaki Takeuchi


Orthopaedics and Traumatology | 2003

Follow-up Study of Ankle Arthrodesis.

Makoto Kimura; Kouji Akasaki; Takaaki Sagara; Takumi Fukumoto; Yoshihiko Kono; Korin Kuwahara; Hidehiko Matsushita; Haruaki Takeuchi

Collaboration


Dive into the Takumi Fukumoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge